Skip to main content

Table 1 Descriptive statistics on study parameters at diagnosis of diabetes and at follow-up

From: Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

  Without previous CVD With previous CVD All patients
n 93,522 11,955 105,477
Malea 50,963 (55) 7,609 (64) 58,572 (56)
Age at diagnosis (years)b 60 (13) 68 (11) 61 (13)
Patients by year of diagnosisa
 1990–December 1999 1,893 (2) 201 (2) 2,094 (2)
 January 2000–December 2004 28,551 (31) 3,741 (31) 32,292 (31)
 January 2005–December 2009 52,317 (56) 6,647 (56) 58,964 (56)
 January 2010 10,761 (12) 1,366 (11) 12,127 (12)
Smoking statusa
 Current smoking 17,545 (19) 2,022 (17) 19,567 (19)
 Ex-smoking 39,016 (42) 6,922 (58) 45,938 (44)
BMI at diagnosis (kg/m2)b 32 (7) 31 (6) 32 (7)
HbA1c at diagnosis (%)b 8.2 (2.2) 7.8 (2.0) 8.1 (2.2)
HbA1c at diagnosis (mmol/mol)b 66 62 65
HbA1C ≥7% (≥53 mmol/mol) post diagnosisa
 Consistently during 1 year post diagnosis 27,375 (29) 3,096 (26) 30,471 (29)
 Consistently during 2 years post diagnosis 20,856 (22) 2,245 (19) 23,101 (22)
CVE during follow-upa
 MI 1,876 (2.01) 569 (4.76) 2,445 (2.32)
 HF 2,295 (2.45) 898 (7.51) 3,193 (3.03)
 Stroke 1,782 (1.91) 485 (4.06) 2,267 (2.15)
 Any CVE 4,293 (6.64) 1,833 (8.39) 6,126 (7.08)
Renal diseasea
 Before diagnosis 16,630 (17.78) 3,116 (26.06) 19,746 (18.72)
 Post diagnosis 25,662 (27.44) 4,601 (38.49) 30,263 (28.69)
Duration of follow-up (years)c 5.0 (3.4, 7.2) 5.4 (3.5, 7.7) 5.3 (3.5, 7.7)
Medicationa
 2 OADs 41,696 (45) 4,515 (38) 46,211 (44)
 Insulin 8,778 (9) 1,004 (8) 9,782 (9)
 OAD + insulin 8,380 (9) 954 (8) 9,334 (9)
 Intensified treatment 44,042 (45) 4,012 (56) 48,036 (46)
  1. aN (%).
  2. bMean (SD).
  3. cMedian (IQR).